Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients

Renal Failure

Volumn 31, Issue 9, 2009, Pages 798-801

  Roozbeh, Jamshid ^a   Hedayati, Parin ^a   Sagheb, Mohammad Mahdi ^a   Sharifian, Maryam ^a   Jahromi, Alireza Hamidian ^b   Shaabani, Sanaz ^a   Jalaeian, Hamed ^a   Raeisjalali, Ghanbar Ali ^a   Behzadi, Saeed ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Cholesterol; ESRD; Hemodialysis patients; Triglyceride; Zinc supplementation

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; ZINC SULFATE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; ZINC BLOOD LEVEL;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DEFICIENCY DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TRIGLYCERIDES; ZINC;

EID: 71049190942     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903216055     Document Type: Article

References (15)

1. Acchiardo S, Moore L, Latour P. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int. 1983;24(Suppl. 16):119.
2. Breslow J. Lipoprotein metabolism. Card Board Rev. 1989;6:10-16.
3. Chevalier CA, Liepa GL, Murphy MD. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Renal Nutr. 2002 July;12(3): 183-189.
4. Condon CJ, Freeman RM. Zinc metabolism in renal failure. Ann Intern Med. 1970;73:531-536.
5. Degoulet P, Legrain M, et al. Mortality risk factors in patients treated by chronic hemodialysis. Nephron. 1982;31:103-110.
6. Duffy TP. Remembering the ABCs. New Engl J Med. 1994;330:994-996.
7. Dvornik S, Cuk M. Serum zinc concentrations in the maintenance hemodialyzed patients. Coll Antropol. 2006 Mar;30(1):259-263.
8. Erten Y, Kayutey M. Zinc deficiency prevalence and causes in hemodialyzed patients and effect on cellular immune response. Transplant Proc. 1998;30:850-885.
9. Jern N, Van Beber AD, Weber CG. The effects of zinc supplementation on serum zinc concentrations and protein catabolic rate in hemodialysis patients. J Renal Nutr. 2000;10:1-7.
10. Lee C, Koo S, Norvell J. Effect of marginal zinc deficiency on the apolipoprotein b concentration of lymph chylomicrons. Fed Proc. 1986;45:974-982.
11. Lee SH, Huang JW. Trace metals abnormalities in hemodialyzed patients, relationship with medications. Artif Organs. 2000 Nov;24(11):841-844.
12. Parsad SA. Recognition of zinc deficiency syndrome. Nutrition. 2001;17:69-76.
13. Sandstead HH. Zinc deficiency: A public health problem? Am J Dis Child. 1991 Aug;145(8):835-839.
14. Vanholder R, Cornelis R. The role of trace elements in uremic toxicity. Nephrol Dial Transplant. 2002;17 (Suppl. 2):2-8.
15. Wu Y, Sun Z. Effects of zinc and selenium on the disorders of blood glucose and lipid metabolism and its molecular mechanism in diabetic rats. Wei Sheng Yan Jiu. 2004 Jan;33(1):70-73.